Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 69353Y103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Samsara BioCapital, L.P.
13G
|
9.9% |
9/15/2026
Event 9/2/2026
|
||
| Samsara BioCapital, L.P. | 5.0% | |||
| Samsara BioCapital GP, LLC | 5.0% | |||
| Samsara Opportunity Fund, L.P. | 5.0% | |||
| Samsara Opportunity Fund GP, LLC | 5.0% | |||
| Srinivas Akkaraju | 9.9% | |||
| BML Investment Partners, L.P. 13G/A | 9.9% |
2/9/2026
Event 12/31/2025
|
||
|
Tang Capital Management LLC
13G
|
8.9% |
9/23/2025
Event 9/16/2025
|
||
| Tang Capital Management, LLC | 8.9% | |||
| Kevin Tang | 8.9% | |||
| Tang Capital Partners, LP | 5.0% | |||
| Tang Capital Partners International, LP | 3.9% | |||
| Tang Capital Partners III, Inc | 0% | |||
| Tang Capital Partners IV, Inc | 0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
| Sio Capital Management, LLC 13G/A | 4.9% |
7/28/2026
Event 6/30/2026
|
||
|
Euclidean Capital LLC
13G/A
|
4.9% |
5/15/2026
Event 3/31/2026
|
||
| Euclidean Capital LLC | 4.9% | |||
| Marilyn H. Simons | 4.9% | |||
| Ashvin B. Chhabra | 4.9% | |||
| Greenland NFP B Ltd. | 2.4% | |||
| Greenland NFP LLC | 0.1% | |||
| Greenland A LLC | 0.7% | |||
| Symmetry Group Ltd. | 0.5% | |||
| ArrowMark Colorado Holdings LLC 13G/A | 3.7% |
7/10/2026
Event 6/30/2026
|
||
|
Orbimed Advisors LLC
13D/A
|
0% |
3/4/2026
Event 3/2/2026
|
||
| Orbimed Advisors LLC | 0% | |||
| Orbimed Capital GP V LLC | 0% | |||
|
PFM Health Sciences, LP
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| PFM Health Sciences, LP | 0% | |||
| PFM Health Sciences GP, LLC | 0% | |||
| Partner Asset Management, LLC | 0% | |||
| Brian D. Grossman | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 67 | 34.6 M | $46.4 M |
| 2026 Q1 | 70 | 37.0 M | $45.8 M |
| 2025 Q4 | 66 | 37.6 M | $47.0 M |
| 2025 Q3 | 65 | 37.5 M | $52.5 M |
| 2025 Q2 | 56 | 35.3 M | $37.4 M |
| 2025 Q1 | 58 | 37.3 M | $40.7 M |
| 2024 Q4 | 73 | 39.0 M | $58.8 M |
| 2024 Q3 | 78 | 39.0 M | $58.2 M |
| 2024 Q2 | 98 | 40.8 M | $66.1 M |
| 2024 Q1 | 106 | 43.7 M | $74.3 M |
| 2023 Q4 | 108 | 51.6 M | $160 M |
| 2023 Q3 | 115 | 56.9 M | $349 M |
| 2023 Q2 | 110 | 51.8 M | $324 M |
| 2023 Q1 | 117 | 51.5 M | $246 M |
| 2022 Q4 | 124 | 57.9 M | $503 M |
| 2022 Q3 | 128 | 58.3 M | $694 M |
| 2022 Q2 | 117 | 61.1 M | $871 M |
| 2022 Q1 | 118 | 55.3 M | $1.15 B |
| 2021 Q4 | 109 | 47.6 M | $1.10 B |
| 2021 Q3 | 93 | 44.0 M | $1.31 B |
| 2021 Q2 | 89 | 43.0 M | $1.47 B |
| 2021 Q1 | 83 | 40.7 M | $1.34 B |
| 2020 Q4 | 74 | 38.2 M | $2.34 B |
| 2020 Q3 | 54 | 31.2 M | $1.10 B |